A new study published in Nature discovered two drugs already on the market, an antifungal and a corticosteroid, may have a new role in treating Multiple Sclerosis. In multiple sclerosis, the breakdown of myelin around axons can lead to muscle weakness, numbness, and problem with visions, coordination and balance. The researchers isolated oligodendrocyte progenitor cells (OPCs) on petri dish and wanted to see if drugs already approved on the market were able to stimulate OPCs to increase myelination. They found out that miconazole and clobetasol stimulated mouth and human OPCs into generating myelin-producing cells. More researches should be done to test these drugs in treating multiple sclerosis in clinical trial however, the results look promising. What are your thoughts about these findings?
For more information, please see NIH.
Image courtesy of [cooldesign]/https://www.freedigitalphotos.net